Novartis not to launch generic version of gleevec29 Jan, 2016, 03.05 PM ISTUSFDA okays safety of Indian medicines28 Mar, 2014, 03.31 PM ISTElder Pharma planning foray in Japanese marketReactor reboot at world's largest nuclear plant highlights flaws in Japan's radioactive waste plans
G7 summit under tight security on both sides of Lake Geneva
Why India is the centerpiece of LG's billion-dollar bet on the Global South
Europe is finally, slowly getting its act together
AirAsia ordered to pay Rs 90,750 after flight delay damages Kerala man's plant
Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?
Indian-American arrested in California for allegedly defrauding bank of $100 million
India warns citizens in Canada against fraudsters posing as consulate officials
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplash
I will be in trouble if I speak the truth: Brij Bhushan Singh on Ram temple fund embezzlement row
AI risks are here, time for tough rules: Anthropic CEO Dario Amodei
Knicks pull off stunning comeback against Spurs in Game 4, one win from NBA title
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service